California Coal Tar Litigation Stay Sought Pending FDA Petition Review
This article was originally published in The Rose Sheet
Executive Summary
California litigation over the use of coal tar in dandruff shampoos and other OTC drugs should be suspended pending FDA review of the ingredient's safety, drug distributor Bergen Brunswig tells a San Francisco judge.